Disclaimer

1. About This Site

This website (the “Site”) is owned and operated by Vigilare Biopharma Pvt Ltd and may include related microsites, blogs, knowledge centers, resource libraries, downloadable assets, event pages, and interactive tools (collectively, the “Vigilare Sites”). Access to and use of the Vigilare Sites is provided subject to the terms below. By using the Site, you accept this Disclaimer in full. If you do not agree, please discontinue use immediately.

2. No Medical or Clinical Advice

Content on the Vigilare Sites including articles, whitepapers, videos, graphics, tools, downloadable guides, and webinar materials is for informational purposes only. It is not intended as medical advice, diagnosis, treatment guidance, or a substitute for consultation with qualified healthcare professionals. Always seek the advice of a physician, pharmacist, or other licensed medical provider with any questions regarding a medical condition, product use, side effect, or treatment decision. Never delay seeking professional medical advice because of something you have read on this Site.

If you think you may be experiencing a medical emergency, contact your local emergency services immediately.

3. Regulatory, Pharmacovigilance & Compliance Information – Informational Only

Vigilare Biopharma Pvt Ltd may publish high‑level summaries of regulatory pathways, pharmacovigilance obligations, product lifecycle considerations, or industry standards. Such content is general in nature and may not reflect the most current laws, authority guidance, or jurisdiction‑specific requirements. Regulatory frameworks vary by country and frequently change. Do not rely on website content as a basis for submissions, compliance decisions, or safety reporting without consulting qualified regulatory, legal, or compliance professionals.

4. Adverse Event or Safety Reporting

The Site is not an official channel for reporting product complaints, adverse drug reactions, device malfunctions, or safety issues. If you need to report a safety concern related to a product:

  • Contact your healthcare provider.

  • Report through the appropriate national health authority or pharmacovigilance channel (e.g., FDA, EMA, CDSCO, MHRA depending on your region).

  • You may also contact us directly at info@vigilarebp.com so we can assist in routing the report appropriately.

Timely reporting helps protect patient safety.

5. No Legal, Financial, or Professional Advice

Nothing on the Vigilare Sites should be construed as legal advice, consulting guidance, financial recommendation, tax advice, or investment advice. Any decisions you make based on the information provided are made at your own risk. Where legal, contractual, or compliance decisions are involved, consult a qualified attorney, regulatory consultant, or licensed professional.

6. Information Accuracy & Currency

We aim to publish accurate, useful, and timely information. However:

  • Content may include errors, omissions, or outdated references.

  • Regulatory and scientific information changes rapidly.

  • Third‑party data, statistics, and external research may be summarized or paraphrased and could later change.

We make no commitment to update content in real time. You are responsible for verifying critical information before acting on it.

7. Use at Your Own Risk / No Warranties

THE SITE AND ALL CONTENT, MATERIALS, DOWNLOADS, SOFTWARE, TOOLS, WEBINARS, AND SERVICES ARE PROVIDED “AS IS” AND “AS AVAILABLE,” WITHOUT ANY WARRANTIES OF ANY KIND, EXPRESS, IMPLIED, OR STATUTORY, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, NON‑INFRINGEMENT, DATA ACCURACY, OR SYSTEM INTEGRATION.

Some jurisdictions do not allow the exclusion of certain implied warranties; in those cases, the above may be limited to the minimum extent required by law.

8. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, Vigilare Biopharma Pvt Ltd, its directors, officers, employees, contractors, content partners, and affiliates shall not be liable for any direct, indirect, incidental, special, consequential, exemplary, or punitive damages arising out of or related to:

  • Use of, or inability to use, the Site or its content;

  • Reliance on information presented;

  • Errors, omissions, interruptions, file corruption, deletion, or data loss;

  • Viruses or system failures that may result from downloading materials;

  • Linked third‑party websites, software, or services.

If applicable law does not allow exclusion of certain damages, our total cumulative liability shall not exceed the lesser of (i) the amount you paid (if any) to access premium services on the Site in the prior 6 months, or (ii) USD $100 (or local equivalent).

9. Third‑Party Links & Content

The Site may link to or embed third‑party websites, videos, regulatory authority resources, publications, calculators, or social media content. These are provided for convenience only. We do not control, endorse, or guarantee the accuracy, security, or availability of third‑party content. Your use of third‑party sites is at your own risk and subject to their terms and privacy policies.

10. Downloads, Tools & Technical Resources

From time to time, the Site may offer downloadable templates, checklists, regulatory trackers, data sheets, slide decks, or software tools. Downloading is at your own risk. We do not warrant that files are free of malware, corruption, or compatibility issues. Always scan downloads and validate data before use in production, compliance, or clinical environments.

11. User Content & Submissions

If the Site allows you to upload, submit, comment, or send materials (collectively, “User Content”):

  • Do not submit confidential, proprietary, or personal health information unless explicitly requested through a secure channel.

  • By submitting User Content, you grant Vigilare Biopharma Pvt Ltd a non‑exclusive, worldwide, royalty‑free license to use, host, reproduce, display, distribute, and create derivative works for Site operations, educational, or marketing purposes (subject to applicable privacy law).

  • We may remove User Content we deem unlawful, infringing, unsafe, or off‑topic.

12. Intellectual Property Notice

Unless otherwise noted, all Site content—including text, graphics, logos, icons, images, video, audio, data compilations, page layouts, and downloadable materials—is owned or licensed by Vigilare Biopharma Pvt Ltd and is protected by copyright, trademark, and other intellectual property laws. Use is governed by our Terms of Use. No license is granted except as expressly set out there.

13. Forward‑Looking Statements & Industry Outlook

Some Site materials (including blog posts, webcasts, or whitepapers) may discuss future plans, product strategies, regulatory outlooks, or industry projections. These forward‑looking statements are inherently uncertain and subject to risks, market conditions, scientific outcomes, and regulatory change. Actual results may differ materially. We undertake no obligation to update forward‑looking statements except as required by applicable law.

14. Geographic & Jurisdictional Differences

Products, services, and regulatory pathways described on the Site may not be available, cleared, registered, or lawful in all countries. Local laws, data rules, import restrictions, and pharmacovigilance obligations vary. Always consult regional experts before acting.

15. Changes to This Disclaimer

We may update this Disclaimer from time to time to reflect legal, regulatory, or business changes. When we do, we will revise the “Last updated” date at the top of this page. Material changes may also be announced through a Site notice or email (where required by law). Continued use of the Site after changes are posted constitutes acceptance of the revised Disclaimer.

16. Contact Us

Questions about this Disclaimer, or requests related to safety reporting, corrections, or permissions? Contact us:

Vigilare Biopharma Pvt Ltd
[Plot no 52,57,1st Floor, Opp:Prerana Hospital Kukatpally, Hyderabad Telangana, India -500072]

Phone: [+91 040 4853 5827]
Email: [info@vigilarebp.com ]

17. Governing Law / Enforcement

This Disclaimer shall be governed by and construed in accordance with the laws of India, without regard to conflict‑of‑laws principles. Any disputes arising out of or relating to the Site shall be subject to the exclusive jurisdiction of the courts located in Hyderabad, Telangana, India, unless applicable law requires otherwise.

18. Language

This Disclaimer may be translated for convenience. The English version controls in the event of any conflict in meaning or interpretation.

19. Severability

If any provision of this Disclaimer is found invalid or unenforceable by a court of competent jurisdiction, the remaining provisions will remain in full force and effect.

 

 

Quick Enquiry
close slider